Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04676399 · ClinicalTrials.gov registry record · Early Phase 1
Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction
A Early Phase 1 study of Hypertension and Chronic Pain, sponsored by University of Kansas Medical Center.
- Active
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT04676399 is a Early Phase 1 study of Hypertension and Chronic Pain that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 36 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04676399, a Early Phase 1 study of Hypertension and Chronic Pain, is active but no longer recruiting, sponsored by University of Kansas Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study (PASSION study) is to monitor symptoms of chronic pain before and after 2 weeks of a standard drug commonly used to treat elevated blood pressure compared with 2 weeks of placebo (crossover design) so that we may better understand how blood pressure affects your level of pain. This study is not testing an experimental drug.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Hydrochlorothiazide 12.5mg
Study Locations (1)
Kansas
- The Marc A. Asher Comprehensive Spine Center at the Kansas University Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-02-08 |
| Est. Completion | 2027-12 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04676399
The ClinicalTrials.gov registry entry for NCT04676399 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Hypertension appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04676399 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT04676399 about?
NCT04676399 is a clinical study titled "Improving Pain Management Via Spinal Cord Stimulation and Blood Pressure Reduction". The purpose of this study (PASSION study) is to monitor symptoms of chronic pain before and after 2 weeks of a standard drug commonly used to treat elevated blood pressure compared with 2 weeks of placebo (crossover design) so that we may better understand how blood pressure affects your level of pa...
What is the current status of trial NCT04676399?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2022-02-08. Estimated completion is 2027-12.
What conditions does trial NCT04676399 study?
This clinical trial studies the following conditions: Hypertension, Chronic Pain, SCS, Diuretics Drug Reactions.
What interventions are being tested in trial NCT04676399?
The interventions under investigation include: Placebo (DRUG), Hydrochlorothiazide 12.5mg (DRUG).
Who is sponsoring clinical trial NCT04676399?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04676399 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Group 1)
RECRUITING · Early Phase 1
-
Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
RECRUITING · Early Phase 1
-
Effect of Empagliflozin on Left Atrial Function in Adults at Risk for Heart Failure
RECRUITING · Early Phase 1
-
Positron Emission Tomography (PET) Imaging of Cholesterol Trafficking: Clinical Evaluation of [18F]FNP-59 in Normal Human Subjects (Groups 2, 3 & 4)
RECRUITING · Early Phase 1
-
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
RECRUITING · Early Phase 1
-
Reversing Glucose and Lipid-mediated Vascular Dysfunction
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.